FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385331349> ?p ?o ?g. }

• W4385331349 endingPage "3247" @default.
• W4385331349 startingPage "3235" @default.
• W4385331349 abstract "To investigate whether sodium-glucose cotransporter-2 (SGLT2) inhibitor use as compared to dipeptidyl peptidase-4 (DPP-4) inhibitor use as add-on to metformin is associated with the risk of any fracture or major osteoporotic fractures (MOFs).A cohort study using the Clinical Practice Research Datalink (CPRD) Aurum database was conducted. All patients aged 18 years and older with a first-ever prescription for a DPP-4 inhibitor or an SGLT2 inhibitor as add-on to metformin between January 1, 2013 and June 30, 2020 were selected. Patients starting with SGLT2 inhibitors were matched (up to 1:3) on propensity scores to patients starting with DPP-4 inhibitors. Propensity scores were calculated based on sex, age, body mass index, comorbidities, comedication and lifestyle factors. Cox proportional hazard models were used to estimate the risk of fracture with SGLT2 inhibitor use as compared to DPP-4 inhibitor use.A total of 13 807 SGLT2 inhibitor users (age 55.4 ± 10.6 years, 36.7% female) were included in this study, matched with 28 524 DPP-4 inhibitor users (age 55.4 ± 8.0 years, 36.4% female). The risk of any fracture with current SGLT2 inhibitor use was similar compared with current DPP-4 inhibitor use (adjusted hazard ratio [aHR] 1.09, 95% confidence interval [CI] 0.91-1.31), as was the risk of MOFs (aHR 0.89, 95% CI 0.64-1.22) and the risk of fractures at any of the individual MOF sites. Additionally, no association was found with duration of SGLT2 inhibitor use (longest duration >811 days) for any of the individual SGLT2 inhibitor agents, or after stratification by sex and age.Use of SGLT2 inhibitors was not associated with the risk of any fracture, MOFs or fracture at the individual MOF sites when compared to DPP-4 inhibitor use." @default.
• W4385331349 created "2023-07-29" @default.
• W4385331349 creator A5032185441 @default.
• W4385331349 creator A5033773549 @default.
• W4385331349 creator A5038962814 @default.
• W4385331349 creator A5050160547 @default.
• W4385331349 creator A5051231925 @default.
• W4385331349 creator A5054171879 @default.
• W4385331349 creator A5058133438 @default.
• W4385331349 creator A5064914075 @default.
• W4385331349 creator A5069730501 @default.
• W4385331349 creator A5084013498 @default.
• W4385331349 date "2023-07-28" @default.
• W4385331349 modified "2023-10-17" @default.
• W4385331349 title "The associations of sodium‐glucose cotransporter‐2 inhibitors versus dipeptidyl peptidase‐4 inhibitors as add‐on to metformin with fracture risk in patients with type 2 diabetes mellitus" @default.
• W4385331349 cites W2002810160 @default.
• W4385331349 cites W2090088543 @default.
• W4385331349 cites W2110768118 @default.
• W4385331349 cites W2119852447 @default.
• W4385331349 cites W2146264128 @default.
• W4385331349 cites W2179831365 @default.
• W4385331349 cites W2468733412 @default.
• W4385331349 cites W2774743973 @default.
• W4385331349 cites W2808317629 @default.
• W4385331349 cites W2884713629 @default.
• W4385331349 cites W2888977383 @default.
• W4385331349 cites W2900732862 @default.
• W4385331349 cites W2927298396 @default.
• W4385331349 cites W2939222610 @default.
• W4385331349 cites W2955795061 @default.
• W4385331349 cites W2959089350 @default.
• W4385331349 cites W2979652934 @default.
• W4385331349 cites W2981693551 @default.
• W4385331349 cites W3048607731 @default.
• W4385331349 cites W3088161326 @default.
• W4385331349 cites W3098262176 @default.
• W4385331349 cites W3149026346 @default.
• W4385331349 cites W4210827470 @default.
• W4385331349 cites W4292315586 @default.
• W4385331349 cites W4303478049 @default.
• W4385331349 doi "https://doi.org/10.1111/dom.15220" @default.
• W4385331349 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37503747" @default.
• W4385331349 hasPublicationYear "2023" @default.
• W4385331349 type Work @default.
• W4385331349 citedByCount "0" @default.
• W4385331349 crossrefType "journal-article" @default.
• W4385331349 hasAuthorship W4385331349A5032185441 @default.
• W4385331349 hasAuthorship W4385331349A5033773549 @default.
• W4385331349 hasAuthorship W4385331349A5038962814 @default.
• W4385331349 hasAuthorship W4385331349A5050160547 @default.
• W4385331349 hasAuthorship W4385331349A5051231925 @default.
• W4385331349 hasAuthorship W4385331349A5054171879 @default.
• W4385331349 hasAuthorship W4385331349A5058133438 @default.
• W4385331349 hasAuthorship W4385331349A5064914075 @default.
• W4385331349 hasAuthorship W4385331349A5069730501 @default.
• W4385331349 hasAuthorship W4385331349A5084013498 @default.
• W4385331349 hasBestOaLocation W43853313491 @default.
• W4385331349 hasConcept C126322002 @default.
• W4385331349 hasConcept C134018914 @default.
• W4385331349 hasConcept C156490143 @default.
• W4385331349 hasConcept C17923572 @default.
• W4385331349 hasConcept C201903717 @default.
• W4385331349 hasConcept C207103383 @default.
• W4385331349 hasConcept C2777180221 @default.
• W4385331349 hasConcept C2778763485 @default.
• W4385331349 hasConcept C2780323712 @default.
• W4385331349 hasConcept C2910068830 @default.
• W4385331349 hasConcept C44249647 @default.
• W4385331349 hasConcept C50382708 @default.
• W4385331349 hasConcept C555293320 @default.
• W4385331349 hasConcept C71924100 @default.
• W4385331349 hasConcept C98274493 @default.
• W4385331349 hasConceptScore W4385331349C126322002 @default.
• W4385331349 hasConceptScore W4385331349C134018914 @default.
• W4385331349 hasConceptScore W4385331349C156490143 @default.
• W4385331349 hasConceptScore W4385331349C17923572 @default.
• W4385331349 hasConceptScore W4385331349C201903717 @default.
• W4385331349 hasConceptScore W4385331349C207103383 @default.
• W4385331349 hasConceptScore W4385331349C2777180221 @default.
• W4385331349 hasConceptScore W4385331349C2778763485 @default.
• W4385331349 hasConceptScore W4385331349C2780323712 @default.
• W4385331349 hasConceptScore W4385331349C2910068830 @default.
• W4385331349 hasConceptScore W4385331349C44249647 @default.
• W4385331349 hasConceptScore W4385331349C50382708 @default.
• W4385331349 hasConceptScore W4385331349C555293320 @default.
• W4385331349 hasConceptScore W4385331349C71924100 @default.
• W4385331349 hasConceptScore W4385331349C98274493 @default.
• W4385331349 hasIssue "11" @default.
• W4385331349 hasLocation W43853313491 @default.
• W4385331349 hasLocation W43853313492 @default.
• W4385331349 hasOpenAccess W4385331349 @default.
• W4385331349 hasPrimaryLocation W43853313491 @default.
• W4385331349 hasRelatedWork W1483551457 @default.
• W4385331349 hasRelatedWork W2082146528 @default.
• W4385331349 hasRelatedWork W2093078000 @default.
• W4385331349 hasRelatedWork W2115304454 @default.
• W4385331349 hasRelatedWork W2126122658 @default.
• W4385331349 hasRelatedWork W2147698512 @default.

• next